clinic
clinic with http://www.md-news.net

clinic

MD News

News for 25-May-20

Source: MedicineNet Prevention and Wellness General
Foods Might Serve Up High Levels of Chemicals Found in Plastics

Source: MedicineNet Senior Health General
Electronic In-Hospital Prescribing: Trouble for Older Adults?

Source: MedicineNet Prevention and Wellness General
With Benefits Unproven, Why Do Millions of Americans Take Multivitamins?

Source: MedicineNet Senior Health General
1 in 4 Seniors Doesn't Discuss End-of-Life Care

Search the Web
cancer
clinic
dead doctors dont lie
dentists
direct doctors plus
doctors advice
doctors consultation
doctors diet lowcarb bar dr
doctors office
doctors offices

The Best clinic website

All the clinic information you need to know about is right here. Presented and researched by http://www.md-news.net. We've searched the information super highway far and wide to provide you with the best clinic site on the internet today. The links below will assist you in your efforts to find the information that you are looking for about
clinic.

clinic

MD News
Need information on medical news? Follow our sponsored links to find information on all of your medical new needs.
MD News

We make clinic searching and shopping easier. We've used our clinic network to get you to be best sites fast and efficiently.

As competition in the clinic world wide marketplace drives the need for ever greater efficiency, the Internet will surely become a better place to do business. The win-win situation between clinic operators and consumers is enormous. Enjoy your clinic adventure by taking advantage of our discoveries. Step one is to click on the links provided in this page.

clinic
dead doctors dont lie
dentists
direct doctors plus
doctors advice
doctors consultation
doctors diet lowcarb bar dr
doctors office
doctors offices
doctors practice
doctors surgery
doctors without borders
dr doctors diet carb block
eye doctors
family doctors
foot doctors
highly skilled doctors
hospital
infertility doctors
laser eye doctors
medical doctors
nursing
patients
pediatrics
practice
spin doctors
cancer

Drug Offers Hope to Cancer Patients

 by: ARA Content

(ARA) - A decade ago, research into angiogenesis-inhibiting compounds was still in a relative state of infancy. The principle itself was not new -- as far back as the early '70s, there was speculation that human cancer tumors could not grow beyond a few millimeters in diameter without obtaining their own blood supply. But opinion was still divided in the scientific community.

Angiogenesis itself is a natural and necessary physiological function, which refers to the process by which new blood vessels form and develop. In its pathological form, however, angiogenesis is also implicated in the progression of more than 20 different diseases, including cancer.

In order to grow, solid tumors need to be supplied by blood vessels that act as conduits for oxygen and nutrients. Once a vascular network has been generated around a tumor, cancerous cells can then invade the rest of the body, a process called metastasis. Angiogenesis inhibitors block the formation of new blood vessels, without which cancerous cells are starved and tumors cannot grow.

In recent years, the therapeutic potential of angiogenesis inhibitors has gained wide acceptance. Indeed, the scientific community now believes that more than 90 percent of all cancer cases are angiogenesis dependent. The industry spends nearly $4 billion annually in angiogenic research and more than 100 research organizations and companies are currently developing angiogenesis-blocking drugs.

∆terna Laboratories Inc. is at the forefront of this effort. In fact, it is one of the very few biotechnology companies in the world with an angiogenesis-blocker in Phase lll clinical development. Its proprietary compound, Neovastat, is currently the subject of Phase III trials in lung and kidney cancer and a Phase ll trial in multiple myeloma, a form of blood cancer.

Neovastat possesses multiple mechanisms of action that counteract the angiogenic process. Among competing products, this makes it unique. It has also shown an excellent safety profile in clinical trials. Further advantages of Neovastat are that it is orally administered, which makes it convenient for patients who must receive treatment on a long-term basis, and it may be taken in association with standard therapies such as chemotherapy.

Angiogenesis blockers are not a cure for cancer. They are a form of treatment -- in the same way that insulin is a treatment for diabetes -- that should allow patients to lead a more normal life, without suffering from the often debilitating side-effects that some treatments can produce.

∆terna's clinical trials strategy has targeted forms of cancer for which there is an urgent need for new therapies. Since 1996, Neovastat has been tested in more than 850 patients in North American and European countries. Currently, Neovastat is the subject of three clinical trials, targeting three forms of cancer. For multiple myeloma, the second most common form of blood cancer, the drug is in Phase II trials with 125 patients in the United States, Canada and Europe. This trial should be completed in early 2003. For progressive renal cell carcinoma, the drug is in Phase III trials with 302 patients in the United States, Canada and Europe, which should be completed in early 2003. For non-small cell lung cancer, Neovastat is in a Phase III trial sponsored by the National Cancer Institute with 760 patients in the United States and Canada. This trial should be completed in 2005.

Once the clinical trials are complete, health authorities in various countries can then assess these results and make decisions on approval.

About The Author

Courtesy of ARA Content, www.ARAcontent.com; e-mail: info@ARAcontent.com

EDITOR'S NOTE: For more information about current trials call (888) 349-3232. For additional information, contact Paul Burroughs, director of communications, (418) 652-8525, Ext. 406. Neovastat is being developed by ∆terna Laboratories of Quebec, Canada.

To learn more about anti-angiogenesis and ∆terna Laboratories, visit the ∆terna Web site at www.aeterna.com. For more information about the NCI's clinical trials, visit http://cancertrials.nci.nih.gov.

Google

http://www.medmeet.com/
Medical Meetings | Take It Correctly | Medical Newscast | Internet Meetings | Medical Newscast

Talk On The Net   Fantasy Football Information   Fantasy Football Update